checkAd

     165  0 Kommentare Dr. Thomas P. Slavin Named Senior Vice President of Medical Affairs for Myriad Oncology - Seite 3

    Media Contact: Ron Rogers Investor Contact: Scott Gleason
      (801) 584-3065   (801) 584-1143
      rrogers@myriad.com   sgleason@myriad.com

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Dr. Thomas P. Slavin Named Senior Vice President of Medical Affairs for Myriad Oncology - Seite 3 SALT LAKE CITY, Jan. 14, 2020 (GLOBE NEWSWIRE) - Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced that it has named Thomas P. Slavin, M.D., FACMG, DABMD, senior vice president of Medical …